Quantcast

Latest CSL Limited Stories

2014-03-01 12:20:36

Analysis also reveals decrease in emergency room visits and hospitalizations SAN DIEGO, March 1, 2014 /PRNewswire/ -- Findings announced by CSL Behring today show that current hereditary angioedema (HAE) treatment options, such as C1 Esterase Inhibitor (C1-INH) concentrate, are allowing for greater patient satisfaction, higher rates of home treatment and a decrease in the number of hospitalizations and visits to the emergency room. HAE is a rare, potentially fatal swelling disorder...

2014-02-27 12:27:13

bioCSL Inc. initiates 2014-15 season pre-booking for AFLURIA® (Influenza Vaccine) KING OF PRUSSIA, Pa., Feb. 27, 2014 /PRNewswire/ -- CSL Biotherapies Inc. announced today it has changed its name to bioCSL Inc., effective February 21, 2014. This change is pursuant to the Australian, New Zealand and German renaming of the company, which occurred one year ago. In September 2013, bioCSL was the first United States supplier to complete its 2013-14 seasonal influenza vaccine delivery...

2014-02-25 20:21:36

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" [http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides...

2014-02-25 12:27:56

DUBLIN, Feb. 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ncdhtt/intravenous ) has announced the addition of the "Concise Analysis of the International Intravenous Immunoglobulin (IVIg) Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million. The report provides separate comprehensive analytics for the US, Canada,...

2014-02-20 08:32:30

Year-round charitable giving includes over $700k to United Way KING OF PRUSSIA, Pa., Feb. 20, 2014 /PRNewswire/ -- You can tell a lot about a company and its employees by the way they give back to the community. CSL Behring, its subsidiary, CSL Plasma and their employees do just that, year-round, supporting a wide range of organizations that provide services to people in need. http://photos.prnewswire.com/prnvar/20100914/PH63692LOGO The annual United Way campaign is the company's single...

2014-02-20 08:32:25

International study by CSL Behring is world's first placebo-controlled phase III trial to examine subcutaneous administration of C1-INH for use in treating rare, sometimes life-threatening, condition KING OF PRUSSIA, Pa., Feb. 20, 2014 /PRNewswire/ -- CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor (C1-INH) concentrate in patients with frequent hereditary...

2014-02-17 08:25:07

LONDON, Feb. 17, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Medical Device Leader Series: Top Needle-Free Injection Device Manufacturers 2014-2024 Report Details Needle-free injecting technologies - discover activities, developments, and prospects of leading companies What does the future hold for makers of needle-free injection (NFI) products? See what's possible. Visiongain's updated report shows you data to 2024 for that industry and...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related